Filing Flows › GSK (GSK) › Q2 2026 › vs Q2 2025
GSK (GSK) Q2 2026 vs Q2 2025 (year over year)
GSK's revenue rose $423M (+5%) from $8.0B in Q2 2025 to $8.4B in Q2 2026. Gross margin 73.1% against 72.9% (+0.2 pts).
GSK, Q2 2026: revenue $8.4B (+5% year over year), operating margin 5.7%, net earnings $435M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 73.1% | 72.9% | +0.2 pts |
| Operating margin | 5.7% | 25.3% | -19.6 pts |
| Net margin | 5.2% | 18.1% | -12.9 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $8.4B | $8.0B | $423M | +5% |
| Gross profit | $6.1B | $5.8B | $322M | +6% |
| Cost of revenue | $2.3B | $2.2B | $101M | +5% |
| Operating profit | $481M | $2.0B | −$1.5B | -76% |
| Operating expenses | $5.7B | $3.8B | $1.9B | +49% |
| Pre-tax earnings | $354M | $1.9B | −$1.5B | -81% |
| Other expense, net | $127M | $136M | −$9.0M | -7% |
| Research & development | $3.5B | $2.0B | $1.4B | +71% |
| Other operating costs | $2.2B | $1.8B | $422M | +24% |
| Income tax benefit | $199M | −$241M | $440M | — |
| Net earnings | $435M | $1.4B | −$1.0B | -70% |
| Minority interests | $118M | $203M | −$85.0M | -42% |
Questions
How much did GSK's revenue grow year over year in Q2 2026?
GSK's revenue rose $423M (+5%) from $8.0B in Q2 2025 to $8.4B in Q2 2026. Gross margin 73.1% against 72.9% (+0.2 pts).